388
Participants
Start Date
October 31, 2006
Primary Completion Date
February 29, 2008
Study Completion Date
February 29, 2008
Eszopiclone
2 mg tablet once per day in the evening
Placebo
Tablet one per day in the evening.
New York
New York
Brooklyn
Mineola
Rochester
Duncansville
Scotland
Allentown
Baltimore
Fairfax
Richmond
Winston-Salem
Cary
Durham
New Bern
Hickory
Anderson Pharmaceutical Research, Anderson
Anderson
Simpsonville
Stockbridge
Atlanta
Maitland
Orlando
Vero Beach
Pembroke Pines
Coral Springs
Gables
West Palm Beach
Delray Beach
Jupiter
St. Petersburg
St. Petersburg
Clearwater
Pinellas Park
Fort Myers
Naples
Sarasota
Birmingham
Lexington
Crestview Hills
Beachwood
Cleveland
Mogadore
Cincinnati
Dayton
Evansville
Vernon Hills
Chicago
Chicago
Florissant
Prairie Village
Overland Park
Baton Rouge
Oklahoma City
Oklahoma City
Oklahoma City
Dallas
Wichita Falls
Houston
San Antonio
San Antonio
San Antonio
Denver
Colorado Springs
Chandler
Glendale
Tucson
Albuquerque
Los Angeles
La Mesa
San Diego
San Diego
San Diego
Irvine
Anaheim
Honolulu
Spokane
Boston
Braintree
Newton
Hamilton
Warwick
Sumitomo Pharma America, Inc.
INDUSTRY